Indian Pharmaceutical Alliance Questions Data Exclusivity Survey; Says Transparency Lacking
This article was originally published in PharmAsia News
Executive Summary
NEW DELHI - The Indian Pharmaceutical Alliance - an association representing 12 leading Indian pharmaceutical companies - has raised strong opposition to a survey on data exclusivity being conducted by the New Delhi-based law firm Anand and Anand